182 related articles for article (PubMed ID: 11140690)
1. Controlled growth factor release from synthetic extracellular matrices.
Lee KY; Peters MC; Anderson KW; Mooney DJ
Nature; 2000 Dec 21-28; 408(6815):998-1000. PubMed ID: 11140690
[TBL] [Abstract][Full Text] [Related]
2. Comparison of VEGF delivery techniques on collateral-dependent microvascular reactivity.
Sellke FW; Tofukuji M; Laham RJ; Li J; Hariawala MD; Bunting S; Simons M
Microvasc Res; 1998 Mar; 55(2):175-8. PubMed ID: 9521892
[No Abstract] [Full Text] [Related]
3. Alginate hydrogels as biomaterials.
Augst AD; Kong HJ; Mooney DJ
Macromol Biosci; 2006 Aug; 6(8):623-33. PubMed ID: 16881042
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
5. Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass.
Keshaw H; Forbes A; Day RM
Biomaterials; 2005 Jul; 26(19):4171-9. PubMed ID: 15664644
[TBL] [Abstract][Full Text] [Related]
6. Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan.
Lee KW; Yoon JJ; Lee JH; Kim SY; Jung HJ; Kim SJ; Joh JW; Lee HH; Lee DS; Lee SK
Transplant Proc; 2004 Oct; 36(8):2464-5. PubMed ID: 15561282
[TBL] [Abstract][Full Text] [Related]
7. Collagenous matrices as release carriers of exogenous growth factors.
Kanematsu A; Yamamoto S; Ozeki M; Noguchi T; Kanatani I; Ogawa O; Tabata Y
Biomaterials; 2004 Aug; 25(18):4513-20. PubMed ID: 15046942
[TBL] [Abstract][Full Text] [Related]
8. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
9. Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds.
Balakrishnan B; Jayakrishnan A
Biomaterials; 2005 Jun; 26(18):3941-51. PubMed ID: 15626441
[TBL] [Abstract][Full Text] [Related]
10. Drilling for oxygen: angiogenesis involves proteolysis of the extracellular matrix.
Libby P; Schönbeck U
Circ Res; 2001 Aug; 89(3):195-7. PubMed ID: 11485968
[No Abstract] [Full Text] [Related]
11. Polymeric system for dual growth factor delivery.
Richardson TP; Peters MC; Ennett AB; Mooney DJ
Nat Biotechnol; 2001 Nov; 19(11):1029-34. PubMed ID: 11689847
[TBL] [Abstract][Full Text] [Related]
12. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH
Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
14. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
Prestwich GD
Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
[TBL] [Abstract][Full Text] [Related]
15. Synthetic extracellular matrices for tissue engineering and regeneration.
Silva EA; Mooney DJ
Curr Top Dev Biol; 2004; 64():181-205. PubMed ID: 15563948
[TBL] [Abstract][Full Text] [Related]
16. The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices.
Yao C; Roderfeld M; Rath T; Roeb E; Bernhagen J; Steffens G
Biomaterials; 2006 Mar; 27(8):1608-16. PubMed ID: 16183114
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion.
Howdieshell TR; Webb WL; Sathyanarayana ; McNeil PL
Surgery; 2003 May; 133(5):528-37. PubMed ID: 12773981
[TBL] [Abstract][Full Text] [Related]
18. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable polyglycolide endovascular coils promote wall thickening and drug delivery in a rat aneurysm model.
Abrahams JM; Forman MS; Grady MS; Diamond SL
Neurosurgery; 2001 Nov; 49(5):1187-93; discussion 1193-5. PubMed ID: 11846912
[TBL] [Abstract][Full Text] [Related]
20. Rho family GTPases regulate VEGF-stimulated endothelial cell motility.
Soga N; Namba N; McAllister S; Cornelius L; Teitelbaum SL; Dowdy SF; Kawamura J; Hruska KA
Exp Cell Res; 2001 Sep; 269(1):73-87. PubMed ID: 11525641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
